Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-069063
Filing Date
2025-07-18
Accepted
2025-07-18 17:00:23
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2521045d1_s3.htm S-3 208512
2 EXHIBIT 5.1 tm2521045d1_ex5-1.htm EX-5.1 10883
3 EXHIBIT 23.2 tm2521045d1_ex23-2.htm EX-23.2 2057
4 EX-FILING FEES tm2521045d1_ex-filingfees.htm EX-FILING FEES 43680
5 GRAPHIC tm2521045d1_ex5-1img001.jpg GRAPHIC 7406
6 GRAPHIC tm2521045d1_ex5-1img002.jpg GRAPHIC 5016
7 GRAPHIC tm2521045d1_ex5-1img003.jpg GRAPHIC 1641
8 GRAPHIC tm2521045d1_s3img001.jpg GRAPHIC 2750
9 GRAPHIC tm2521045d1_s3img002.jpg GRAPHIC 3130
  Complete submission text file 0001104659-25-069063.txt   294554
Mailing Address 23461 SOUTH POINTE DRIVE, SUITE 390 LAGUNA HILLS CA 92653
Business Address 23461 SOUTH POINTE DRIVE, SUITE 390 LAGUNA HILLS CA 92653 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288776 | Film No.: 251135076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)